Website profile

Via Tt

via.tt.se
All articles Clear site filter
  • 68articles · 30d
  • 7+ hour agolatest article
  • Aug 17, 2026earliest in window
  • 99%with images
  • 277avg words
articles per day
Covers
People
Places
Organizations
Categories
  • Economy, Business & Finance 49
  • Finance & Business 44
  • News 26
  • Business & Industrial 15
  • Science & Technology 13
  • Finance 8
  • Medical 7
  • Health & Wellness 7

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Via TT
via.tt.se > pressmeddelande > 4523450 > beone-medicines-announces-voluntary-agreement-with-us-government-to-expand-access-to-innovative-cancer-medicines

BeOne Medicines Announces Voluntary Agreement with U.S. Government to Expand Access to Innovative Cancer Medicines | Business Wire

1+ week, 6+ day ago   (914+ words) BeOne Medicines, Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced a voluntary agreement with the U.S. Government to expand access to innovative cancer medicines for American patients while strengthening our U.S manufacturing footprint and further expanding the capabilities…...

Via TT
via.tt.se > pressmeddelande > 4515333 > virtus-respiratory-research-supports-development-of-apollo-therapeutics-apl-10456-from-preclinical-proof-of-concept-to-positive-phase-1-data

VirTus Respiratory Research Supports Development of Apollo Therapeutics’ APL-10456 from Preclinical Proof of Concept to Positive Phase 1 Data | Business Wire

2+ week, 5+ day ago   (236+ words) 26.8.2026 10:00:00 CEST | Business Wire | Press Release VirTus Respiratory Research Ltd, a specialist respiratory contract research organisation (CRO), founded by Imperial College London investigators Professor Sebastian Johnston and Dr Michael Edwards, today highlighted its role in the preclinical development of Apollo Therapeutics…...